Siebel, whose fortunes soared with the tech boom, has cut nearly one-third of its workforce since the end of 2001.
Siebel, whose prosperity has increased with the technological boom, has reduced close to one-third of its workforce since the end of 2001.
The first biotechnology treatment for asthma , the constriction of the airways that affects millions around the world , received approval from the US Food and Drug Administration yesterday .